Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Candesartan Added Treatment for Optimisation of Heart Failure Therapy
2004-003962-14Phase 3Completed
- Sponsor
- Takeda
- Start
- Dec 2004
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of candesartan cilexetil in heart failure (HF), sponsored by Takeda. Primary endpoint: Course of BNP. Started Dec 2004; status: completed.
02
Drugs
candesartan cilexetil
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on 2004-003962-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-003962-14.